ConductScience.org, home

Paper3729367

In vitro evaluation of various antifungal agents alone and in combination by using an automatic turbidimetric system combined with viable count determinations.

Van der Auwera P and 3 others. Antimicrob Agents Chemother, 1986. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. In vitro evaluation of various antifungal agents alone and in combination by using an automatic turbidimetric system combined with viable count determinations. Papers, record 3729367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3729367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro evaluation of various antifungal agents alone and in combination by using an automatic turbidimetric system combined with viable count determinations.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1986
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.69
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Van der Auwera PP
2Ceuppens AMA M
3Heymans CC
4Meunier FF

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifungal AgentsMajor topic
Amphotericin B
Drug Interactions
Flucytosine
Ketoconazole
Microbial Sensitivity Tests
Nephelometry and Turbidimetry

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15672740Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy.Am J Med1968https://conductscience.org/library/papers/5672740PubMed
23517051Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B.J Clin Microbiol1986https://conductscience.org/library/papers/3517051PubMed
35118468Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms.Proc Soc Exp Biol Med1971https://conductscience.org/library/papers/5118468PubMed
44550505Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).Proc Natl Acad Sci U S A1972https://conductscience.org/library/papers/4550505PubMed
55054147Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum.Science1972https://conductscience.org/library/papers/5054147PubMed
61090685Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice.J Infect Dis1975https://conductscience.org/library/papers/1090685PubMed
7984806Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984806PubMed
8646347
Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods.
Antimicrob Agents Chemother1978https://conductscience.org/library/papers/646347PubMed
96993624Disappearance of nystatin resistance in Candida mediated by ergosterol.J Gen Microbiol1980https://conductscience.org/library/papers/6993624PubMed
106993625Inhibition of sterol biosynthesis in Candida albicans by imidazole-containing antifungals.J Gen Microbiol1980https://conductscience.org/library/papers/6993625PubMed
116250469In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6250469PubMed
127247356Experimental intraabdominal candidiasis in rabbits: therapy with low-total-dose intravenous amphotericin B.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7247356PubMed
137055395Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B.Ann Surg1982https://conductscience.org/library/papers/7055395PubMed
147038330Chemotherapy of the systemic mycoses.Med Clin North Am1982https://conductscience.org/library/papers/7038330PubMed
156295266Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6295266PubMed
166343524Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model.J Infect Dis1983https://conductscience.org/library/papers/6343524PubMed
176356283Antifungal action of rifampin.Rev Infect Dis1983https://conductscience.org/library/papers/6356283PubMed
186356284Interaction of rifampin with other antifungal agents in experimental murine candidiasis.Rev Infect Dis1983https://conductscience.org/library/papers/6356284PubMed
196356285Combination antifungal chemotherapy for experimental disseminated candidiasis: lack of correlation between in vitro and in vivo observations with amphotericin B and rifampin.Rev Infect Dis1983https://conductscience.org/library/papers/6356285PubMed
203973417Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study.J Infect Dis1985https://conductscience.org/library/papers/3973417PubMed

See all 21 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
29370698Discovery of a Novel Dibromoquinoline Compound Exhibiting Potent Antifungal and Antivirulence Activity That Targets Metal Ion Homeostasis.ACS Infect Dis2018https://conductscience.org/library/papers/29370698PubMed
15015031Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.Eur J Clin Microbiol Infect Dis2004https://conductscience.org/library/papers/15015031PubMed
9350751Comparison of a photometric method with standardized methods of antifungal susceptibility testing of yeasts.J Clin Microbiol1997https://conductscience.org/library/papers/9350751PubMed
8269392Antifungal susceptibility testing.Clin Microbiol Rev1993https://conductscience.org/library/papers/8269392PubMed
7695274New in vitro assay based on glucose consumption for determining intraconazole and amphotericin B activities against Aspergillus fumigatus.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7695274PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3729367

GET https://conductscience.org/api/papers/v1/3729367/references?page=2